Nimenrix

Nimenrix
  • Contraindication

    Hypersensitivity to active substances or any excipients included in the vaccine

  • Side effects

    loss of appetite; insomnia; irritability; headache; drowsiness; dyspeptic disorders; temperature increase; swelling and soreness at the injection site. Less often can be observed: reduced sensitivity to external stimuli, itching, rash, muscle pain, tightness, feeling of heat at the injection site.

Nimenrix

2600 UAH
  • Producing country:Belgium
  • Composition and form of release:Powder and solvent for solution for injection

Against what:
coronavirusMeningococcal infection

note_alt Sign up for vaccinations

Application

Immunization should be performed only by intramuscular injection. In infants, the recommended injection site is the anterolateral thigh. In persons older than 1 year, the recommended injection site is the anterolateral part of the thigh or the deltoid muscle.

  • Indication

    Nimenrix® vaccine is indicated for active immunization of individuals 6 weeks of age and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y.